Why the application of IVIG might be beneficial in patients with COVID-19 - Authors' reply

Lancet Respir Med. 2022 Feb;10(2):e16. doi: 10.1016/S2213-2600(21)00550-6.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • COVID-19*
  • Humans
  • Immunoglobulins, Intravenous*
  • SARS-CoV-2

Substances

  • Immunoglobulins, Intravenous